Lv1
70 积分 2024-01-31 加入
Base Editing Might Be Key to CAR T-cell Therapy
28天前
已关闭
CAR T or NK cells targeting mismatched HLA-DR molecules in acute myeloid leukemia after allogeneic hematopoietic stem cell transplant
1个月前
已完结
Preclinical development and a case report of a nanobody-based CLDN18.2 CAR-T IMC002 with reduced on-target off-tumor toxicity
1个月前
已完结
A bispecific anti-fluorescein x anti-CD3 T-cell engager in combination with fluoresceinated adaptors enables lysis of AML cells
1个月前
已关闭
High affinity CD16v/v allogeneic NK cell therapy, AB-101, enhances antibody-mediated cytotoxicity in B-cell driven diseases
1个月前
已关闭
Cystine Restriction Alleviates T Cell Exhaustion and Enhances CAR-T Cell Potency
1个月前
已完结
B-cell activating factor receptor expression in B-lymphoblastic leukaemia: Flow cytometric analysis and implications for targeted therapy
1个月前
已完结
Cytokine co-presentation on targeted lipid nanoparticles enhances in vivo T cell engineering
1个月前
已完结
Cis- and trans-binding chimeric costimulatory receptors enhance T-cell fitness and tumor control
1个月前
已完结
A phase 1/2 study of donor-derived anti-CD33 CAR T-cell therapy (VCAR33) for relapsed/refractory AML after allogeneic HCT
1个月前
已完结
皖公网安备34019202002308
